Back to top

Image: Bigstock

Mazor Robotics (MZOR) Catches Eye: Stock Moves Up 10.2%

Read MoreHide Full Article

Mazor Robotics Ltd. was a big mover last session, as its shares rose over 10% on the day. The move came after the company received the FDA clearance for its Mazor X Align™ software. Mazor X Align is designed to assist surgeons in planning spinal deformity correction and spinal alignment for procedures performed with the Mazor X Surgical Assurance Platform. This also led to far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $31.37 to $33.99 in the past one-month time frame.

The company has seen one negative estimate revision in the past 30 days and its Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher can last.

Mazor Robotics currently carries a Zacks Rank #4 (Sell), while its Earnings ESP is 0.00%.

A better-ranked stock in the Medical - Instruments space is Hologic, Inc. (HOLX - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is MZOR going up? Or down? Predict to see what others think: Up or Down
    
Zacks' Hidden Trades


While we share many recommendations and ideas with the public, certain moves are hidden from everyone but selected members of our portfolio services. Would you like to peek behind the curtain today and view them?                                                                                                                                                                 

Starting now, for the next month, I invite you to follow all Zacks' private buys and sells in real time from value to momentum...from stocks under $10 to ETF to option movers...from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors.

Click here for Zacks' secret trade>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Hologic, Inc. (HOLX) - free report >>

Published in